This webcast will discuss Advances in Liver Disease. Viewers should expect to understand the scope of steatotic liver disease and the increasing burden on the current healthcare system.  The program will discuss management of steatotic liver disease including novel pharmacologic treatment options; discuss new first line systemic therapy options for patients with unresectable hepatocellular carcinoma; introduce the changing landscape of hepatocellular carcinoma management including combination therapy, novel biomarkers, and the role of liver transplantation; and discuss recent advances in autoimmune hepatitis and a potential new first line therapy option.

Link to transcript